Log in | Join Free | china | japan | germany

SNDX-5613

Request For Quotation
SNDX-5613 Suppliers list
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: Product Name:sndx-5613
CAS:2169919-21-3
Purity:98% Package:10MG;50MG;100MG,1G,5G,10G
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:SNDX-5613
CAS:2169919-21-3
Purity:98.00% Package:1 mg；10 mg；100 mg；200 mg；25 mg；5 mg；50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Wuhan Nutra Biotechnology Co.,Ltd
Tel: +8617786394783
Email: nutrabiotech@outlook.com
Products Intro: Product Name:SNDX-5613
CAS:2169919-21-3
Purity:98% Package:150box;1USD
Company Name: Zhejiang J&C Biological Technology Co.,Limited
Tel: +1-2135480471 +1-2135480471
Email: sales@sarms4muscle.com
Products Intro: Product Name:SNDX-5613 SNDX5613
CAS:2169919-21-3
Purity:99% Package:5KG;1KG Remarks:SNDX-5613 SNDX5613
Company Name: Nantong HI-FUTURE Biology Co., Ltd.
Tel: +undefined18051384581
Email: sales@chemhifuture.com
Products Intro: Product Name:SNDX-5613
CAS:2169919-21-3
Purity:98%+ HPLC Package:100MG,500MG,1G,5G,10G 50MG

SNDX-5613 manufacturers

  • SNDX-5613
  • SNDX-5613 pictures
  • $1.00 / 150box
  • 2022-11-21
  • CAS:2169919-21-3
  • Min. Order: 1box
  • Purity: 98%
  • Supply Ability: 1
SNDX-5613 Basic information
Product Name:SNDX-5613
Synonyms:SNDX-5613;acute,Leukemia,inhibit,lymphoblastic,Epigenetic Reader Domain,Inhibitor,AML,Menin,ALL,SNDX 5613,SNDX-5613,SNDX5613,MLL,myeloid;Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)-;SNDX-5613 SNDX5613;Revumenib
CAS:2169919-21-3
MF:C32H47FN6O4S
MW:630.82
EINECS:
Product Categories:
Mol File:2169919-21-3.mol
SNDX-5613 Structure
SNDX-5613 Chemical Properties
Boiling point 739.1±70.0 °C(Predicted)
density 1.28±0.1 g/cm3(Predicted)
solubility DMSO:30.0(Max Conc. mg/mL);47.56(Max Conc. mM)
pka11.10±0.40(Predicted)
Safety Information
MSDS Information
SNDX-5613 Usage And Synthesis
SNDX-5613 Preparation Products And Raw materials
Tag:SNDX-5613(2169919-21-3) Related Product Information
SNS-062 PF-04929113 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide hydrochloride N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea